TherapeuticsMD(TXMD) - 2021 Q3 - Earnings Call Transcript

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q3 Earnings Conference Call November 11, 2021 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Rob Finizio – Chief Executive Officer Hugh O’Dowd – President James D'Arecca – Chief Financial Officer Mark Glickman – Chief Commercial Officer Conference Call Participants Louise Chen – Cantor Fitzgerald Annabel Samimy – Stifel Douglas Tsao – HC Wainwright Operator Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD, Third Quarter ...